| __timestamp | Travere Therapeutics, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47795223 | 22223073 |
| Thursday, January 1, 2015 | 50426000 | 6966842 |
| Friday, January 1, 2016 | 70853000 | 9000499 |
| Sunday, January 1, 2017 | 78168000 | 13741186 |
| Monday, January 1, 2018 | 123757000 | 19040000 |
| Tuesday, January 1, 2019 | 140963000 | 23559000 |
| Wednesday, January 1, 2020 | 131773000 | 31931000 |
| Friday, January 1, 2021 | 210328000 | 44981000 |
| Saturday, January 1, 2022 | 235780000 | 54234000 |
| Sunday, January 1, 2023 | 244990000 | 63806000 |
Cracking the code
In the ever-evolving world of biotechnology, research and development (R&D) investments are crucial for driving innovation and maintaining competitive advantage. Over the past decade, Travere Therapeutics, Inc. and Viking Therapeutics, Inc. have demonstrated distinct R&D strategies. From 2014 to 2023, Travere consistently outpaced Viking, with R&D expenses growing by over 400%, peaking at nearly $245 million in 2023. In contrast, Viking's R&D investments increased by approximately 187%, reaching $64 million in the same year.
This divergence highlights Travere's aggressive approach to innovation, potentially positioning it as a leader in therapeutic advancements. Meanwhile, Viking's more conservative spending may reflect a strategic focus on targeted research areas. As the biotech landscape continues to shift, these investment patterns offer valuable insights into each company's long-term vision and commitment to pioneering healthcare solutions.
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Verona Pharma plc vs Travere Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.
Research and Development: Comparing Key Metrics for Protagonist Therapeutics, Inc. and Travere Therapeutics, Inc.
Analyzing R&D Budgets: Travere Therapeutics, Inc. vs Xencor, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds